🦊/Lists

Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
McWin Capital Partners
LondonSeries B–Late Stage
32 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
18 people
HCVC
ParisPre-Seed–Series A$100K – $1M
6 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
18 people
K3 Ventures
SingaporeSeed–Growth$1.2M – $42M
23 people
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
Faber
LisbonPre-Seed–Series A$2.7M
18 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
7 people
Farvatn Venture
Bergen
1 person
Apollo Health Ventures
BerlinSeed–Series A
29 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
SucSEED Indovation
HyderabadPre-Seed–Growth$4K – $1.1M
11 people
Metavallon VC
AthensPre-Seed–Series A$220K – $1.6M
11 people
Nucleus Capital
BerlinPre-Seed–Series A$1M – $1.1M
22 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Fly Ventures
BerlinPre-Seed–Series A$1.1M – $4.3M
6 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
27 people
Pangaea Ventures Us Inc.
VancouverSeed–Late Stage$500K – $1.5M
13 people
Saltagen Ventures
Hong KongSeed–Series B
21 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.